Cyclospora: A Clinical Guide to Diagnosis, Testing, and Treatment

Every summer, clinicians are reminded that not all prolonged diarrhea is viral. As reports of Cyclospora cayetanensis infections increase across the United States, it's worth refreshing ourselves on a pathogen many clinicians rarely encounter outside of outbreaks.

The good news? Cyclospora is treatable. The challenge is recognizing it, ordering the correct diagnostic test, and knowing what to do when first-line therapy isn't an option.

Think Cyclospora When Diarrhea Lasts More Than One Week

Cyclospora should move higher on your differential when patients present with:

• Prolonged watery diarrhea (often >7 days)
• Intermittent or relapsing symptoms
• Fatigue that seems out of proportion to illness
• Abdominal cramping
• Bloating
• Nausea
• Weight loss
• Low-grade fever (less common)

Unlike norovirus or other viral gastroenteritis, symptoms often persist for weeks without treatment and may wax and wane. This isn’t your typical 48 - 72 hour stomach bug.

Cyclospora is often spread in the summer months through the consumption of fresh produce, including leafy greens, herbs, berries, and other imported fruits and vegetables.

Ordering the Right Test Matters

The biggest pitfalls clinicians face are assuming that routine stool studies will detect Cyclospora. They won't. The second biggest pitfall is mistaking Cyclospora for Cryptosporidium — they are different.

Let's take a look at testing:

Molecular Testing

When available, Cyclospora-specific PCR should be the test of choice. PCR offers improved sensitivity and faster diagnosis. Keep in mind that many GI PCR panels do not include Cyclospora, so call the lab and make sure you are ordering the correct test.

Stool Ova & Parasite (O&P)

A routine O&P is an attractive test to order because it is used to test for parasites; however, the exam has important limitations:

• Cyclospora may not be specifically evaluated on an O&P unless requested.
• Organism shedding can be intermittent and may not be caught on every sample. Routine testing recommendations are multiple stool studies collected on different days.
• A single negative specimen does not exclude infection.

What about Treatment?

First Line: Trimethoprim-sulfamethoxazole is the treatment of choice supported by strong evidence for cyclosporiasis. The recommended adult dose is one double-strength tablet (160 mg TMP/800 mg SMX) twice daily for 7–10 days.

Note: For immunocompromised patients, the treatment course may be longer, and relapse is more frequent, requiring a more intensive management plan.

Alternative Options:

Ciprofloxacin: Ciprofloxacin is most often used in patients who cannot take TMP-SMX. When considering ciprofloxacin, keep in mind that studies suggest it is less effective and is not considered an equivalent alternative.

Nitazoxanide: Often mentioned as an alternative option. Limited data suggest nitazoxanide may have some activity against Cyclospora. This medication is not always routinely stocked at pharmacies, so expect some delays in obtaining and a higher price tag.

What If My Patient Has a Sulfa Allergy?

This is probably the most common management question during outbreaks. Unfortunately, there is no equally effective alternative to TMP-SMX.

Alternatives, like ciprofloxacin, have limited evidence and generally lower efficacy.

Management depends on illness severity and the nature of the allergy.

• Mild illness: Supportive care and observation are reasonable, as many immunocompetent patients with mild illness recover without antibiotics. Shared decision making with patients is helpful when supportive care is chosen. Patients should be informed diarrhea is often prolonged and can be relapsing.

• Moderate to severe illness: Confirm whether the reported sulfa allergy is a true allergic hypersensitivity. For patients with non-severe reactions, TMP-SMX desensitization may be considered in consultation with an allergist.

• Do not pursue desensitization in patients with severe delayed reactions such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), DRESS, or other severe T-cell-mediated reactions.

Don't Forget About Supportive Care

Even when antibiotics are prescribed, supportive care remains essential. The biggest clinical concern for these patients is dehydration from prolonged diarrhea.

• Oral rehydration (or IV fluids when indicated)
• Electrolyte replacement
• Early nutritional support as tolerated

Should Household Contacts Be Treated?

No. Unlike many enteric pathogens, Cyclospora is not typically transmitted directly from person to person.

Current recommendations:

• Do not provide prophylactic antibiotics to asymptomatic household contacts.
• Evaluate and test contacts only if they develop compatible symptoms.

Reinforce good hand hygiene and safe food preparation practices.

Reporting Cases Matters

Cyclospora is a nationally notifiable disease. Confirmed or suspected cases should be reported to the health department.

During the current outbreak, clinicians should consider Cyclospora in patients with persistent watery diarrhea lasting more than a week, particularly when symptoms are relapsing. Don't assume that routine GI PCR panels or stool ova and parasite testing will detect the infection — if clinical suspicion is high, specifically request Cyclospora testing. TMP-SMX remains the only evidence-supported first-line treatment, and no equally effective alternative has been identified. Early recognition, appropriate testing, and timely reporting to public health can improve patient outcomes and help identify foodborne outbreaks more quickly.